Anti-Candida, Anti-Enzyme Activity and Cytotoxicity of 3,5-Diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides

Bibliographic Details
Title: Anti-Candida, Anti-Enzyme Activity and Cytotoxicity of 3,5-Diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides
Authors: Simone Oliveira, Lucas Pizzuti, Frank Quina, Alex Flores, Rafael Lund, Claiton Lencina, Bruna S. Pacheco, Claudio M. P. de Pereira, Evandro Piva
Source: Molecules, Vol 19, Iss 5, Pp 5806-5820 (2014)
Publisher Information: MDPI AG, 2014.
Publication Year: 2014
Collection: LCC:Organic chemistry
Subject Terms: pyrazoles, Candida albicans, antifungal activity, anti-enzyme activity, Organic chemistry, QD241-441
More Details: Because of the need for more effective and less harmful antifungal therapies, and interest in the synthesis of new carboximidamides, the goal of this study was to determine the antifungal and anti-enzyme activities of some new pyrazole carboximidamides and their cytotoxicity. For this purpose, tests were performed to evaluate: minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC); production of proteinases and phospholipase, and cytotoxicity of the extracts. Data were analyzed by ANOVA and Tukey Tests (α = 5%). The results were: MIC and MFC ≥ 62.5 μg/mL (C. albicans, C. parapsilosis, C. famata, C. glabrata, and Rhodotorula mucillaginosa) and MIC and MFC ≥ 15.6 μg/mL (C. lipolytica). The values of proteinase and phospholipase (Pz) of C. albicans before and after exposure to the compounds were: 0.6 (±0.024) and 0.2 (±0.022) and 0.9 (±0.074) and 0.3 (±0.04), respectively. These proteinase results were not significant (p = 0.69), but those of phospholipase were (p = 0.01), and 15.6 μg/mL was the most effective concentration. The cytotoxicity means were similar among the tests (p = 0.32). These compounds could be useful as templates for further development through modification or derivatization to design more potent antifungal agents. Data from this study provide evidence that these new pyrazole formulations could be an alternative source for the treatment of fungal infections caused by Candida. However, a specific study on the safety and efficacy of these in vivo and clinical trials is still needed, in order to evaluate the practical relevance of the in vitro results.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1420-3049
Relation: http://www.mdpi.com/1420-3049/19/5/5806; https://doaj.org/toc/1420-3049
DOI: 10.3390/molecules19055806
Access URL: https://doaj.org/article/23b32ddf84334f129c4e50245a2fc21c
Accession Number: edsdoj.23b32ddf84334f129c4e50245a2fc21c
Database: Directory of Open Access Journals
More Details
ISSN:14203049
DOI:10.3390/molecules19055806
Published in:Molecules
Language:English